ONESOURCEOnesource Specialty Pharma Limited Forensic Risk Analysis

Pharmaceuticals
Risk ClassModerate Deterioration
Market Cap₹16,196 Cr
Primary DriverBalance Sheet Stress
Flagium AI Risk Score
Moderate stress emerging. While not critical, underlying pressure is building.
45 / 100
+21 QoQ
Early Deterioration
Sentinel Insight

Some early signs of pressure are visible. Weakness is detected in balance sheet stress. This suggests a building risk profile. Risk is increasing at a faster pace.

96.0th %ile (Sector)Accel: +1 Qtrs
Updated2026-06-02
Market View
1,828.60.5%
PeriodQ4 FY26

Score Waterfall
Absolute contribution points of each forensic pillar to the final risk score. Derived from: Sector Baseline + Active Penalties - Mitigation Buffers.

Balance Sheet Stress
+20.0 pts
Earnings Quality
+15.0 pts
Growth Sustainability
+10.0 pts
Final Composite Risk45 / 100

Investment Risk Thesis

Historical Trend

Current risk score has risen from 045 over 12 quarters.

Expected Direction
🚨 Escalate
Primary Deterioration Drivers
  • Margin Compression
  • Inventory Stress
  • Industrial Margin Stress
What to Watch Next Quarter
  • Operating profit margins
  • Working capital efficiency
  • Inventory turnover

Active Risk Objects (9)

CriticalHigh
Industrial Margin Stress
📊 Earnings QualityAnnualActive for 4 Years
More Detail
Impact Weight12/15
MomentumPersistent
Last SignalQ4 FY2026
ONESOURCE: EBITDA margin compressed by 18.8 bps YoY and Raw material costs consumed an additional 12.4% of revenue YoY.

"Early signs of margin erosion. Input costs are beginning to eat into core profits."

Working Capital Expansion
💧 Liquidity & CoverageAnnualActive for 4 Years
More Detail
Impact Weight10/15
MomentumPersistent
Last SignalQ4 FY2026
Working capital expansion detected: Receivable days increased by 65.1%.

"Early signs of working capital expansion. Receivable or inventory days are creeping up."

Margin Compression
📊 Earnings QualityAnnualActive for 1 Years
More Detail
Impact Weight15/15
MomentumAccelerating
Last SignalQ4 FY2026
Operating margin declined by 19.5 bps YoY for two consecutive quarters.

"Early signs of margin erosion. Input costs are beginning to eat into core profits."

Capex Efficiency Stress
📊 Earnings QualityAnnualActive for 1 Years
More Detail
Impact Weight8/15
MomentumDecaying
Last SignalQ2 FY2025
Aggressive Capex (43.8%) amidst slow revenue growth (-95.3%).

"Earnings quality is stabilizing. The reliance on non-operational items is receding."

Inventory Stress
📊 Earnings QualityAnnualActive for 3 Years
More Detail
Impact Weight15/15
MomentumPersistent
Last SignalQ4 FY2026
Inventory growth (177.7%) significantly outpaced revenue growth (0.3%).

"Stock is piling up in the warehouse. Inventory turnover is slowing down dangerously."

Operating Leverage Stress
📊 Earnings QualityAnnualActive for 1 Years
More Detail
Impact Weight10/15
MomentumAccelerating
Last SignalQ4 FY2026
Expenses are consistently growing faster than revenues, creating operational pressure.

"The balance sheet is heavily over-leveraged. Interest payments are consuming most of the profit."

Profit Collapse
📊 Earnings QualityQuarterlyActive for 1 Qtrs
More Detail
Impact Weight8/15
MomentumAccelerating
Last SignalQ4 FY2026
ONESOURCE: Net Profit collapsed by 95.3% from FY2025 Q4 to FY2026 Q4.

"Earnings quality is under severe pressure. High accruals suggest potential revenue overstatement."

Low Interest Coverage
💧 Liquidity & CoverageQuarterlyActive for 6 Qtrs
More Detail
Impact Weight8/15
MomentumPersistent
Last SignalQ4 FY2026
ONESOURCE: Low Interest Coverage Ratio of 0.99x in FY2026 Q4 (Threshold: 2.5x).

"Interest coverage is dangerously low. Even a minor fall in profit could trigger a default."

Revenue-Debt Divergence
🏛️ Solvency & LeverageAnnualActive for 1 Years
More Detail
Impact Weight6/15
MomentumAccelerating
Last SignalFY2026
ONESOURCE: Revenue fell 1.8% while Debt rose 65.4% in 2026 vs 2025.

"Debt levels are creeping up. Monitor for signs of excessive borrowing for non-core activities."

Risk Trajectory
Historical 12-quarter risk trend (Q-11 to Q0) followed by a 2-quarter predictive funnel (Q+1, Q+2).
Loading Chart
Resilience Matrix
Diagnostic benchmarking comparing structural sensitivity and risk buffers against sector medians.
MetricValuevs SectorSignal
Volatility (σ)9.557.70⚠️ HIGH
Sensitivity (ε_s)11.00✅ RESILIENT
Escalation Prob.5%5%✅ NEUTRAL
Safety Buffer+21.0+47.0📈 CRITICAL
Forensic Benchmark Context: Pharmaceuticals (n=99 peers)

Correlation Analysis
Visualizing the relationship between stock price movement and structural risk objects.

Loading Chart
Share Price
Risk Score (0-100)
Market Performance
1,828.6(-0.5%)
1M Divergence+2.94%
1 Week+1.27%
1 Month+5.21%
6 Months+9.64%
1 Year-3.16%
2 Year+15.62%
3 Year+15.62%
Sector Average (1M)+2.27%
Sentinel Forensic Assessment
ALGORITHMIC RISK PROFILE • NON-ADVISORY

The risk profile is Moderate Stress and currently deteriorating. Recent structural triggers in balance sheet stress suggest a building pressure on the underlying framework. Material forensic traces are visible in core structural metrics, indicating a progressive erosion of structural stability. Strategic vigilance is advised as structural decay is accelerating.

ONESOURCE • MARKET STRUCTURE

Stage 1 — Accumulation

The company is in a foundational phase. Risk metrics are stabilizing as the company builds a base for potential future fundamental improvement.

Stage Transition Prob.40%
Trend QualityStabilizing
Phase Progression
Phase Progression Score55%
Readiness LabelModerate (Transition Potential Building)
Probability of Advancing40%
CoinTree Momentum
Composite Z-Score+0.6556σ
Improving momentum strength
Universe Rank
A cross-sectional rank of this stock's composite momentum score compared to all other tracked equities in the universe. A rank of #1 of 1035 means it has the strongest overall price momentum in the market.
#365 of 2716
Top 13.44% in momentum strength
Timeframe Sparklines
1W+1.3%
1M+5.2%
6M+9.6%
Weinstein Indicators
150 DMA1,597.46
200 DMA1,660.05
150 DMA Slope-0.0971%Declining
Relative Strength+15.13%Leading
Relative Turnover (RTR)2.1708
ParticipationHealthy

PEER COMPARISON

Ranked comparison against sector peers

This company shows higher risk compared to the Sector Mean (19).

* Peer comparison is based on risk signals, not valuation or returns.

Risk Profiles

Solvency
10100th %ile
VS Sector Median (8.5)
Governance
10100th %ile
VS Sector Median (8.5)
Earnings Quality
00th %ile
VS Sector Median (8.5)
Balance Sheet Stress
00th %ile
VS Sector Median (8.5)
Competitive Position
10100th %ile
VS Sector Median (8.5)
Growth Sustainability
00th %ile
VS Sector Median (8.5)

Deterioration Timeline

2026

Operating Leverage Stress

2026

Margin Compression

2026

Industrial Margin Stress

2026

Inventory Stress

2026

Working Capital Expansion

2026

Industrial Margin Stress

2026

Industrial Margin Stress

2026

Inventory Stress

2026

Working Capital Expansion

2026

Industrial Margin Stress

2026

Revenue-Debt Divergence

2025

Inventory Stress

2025

Working Capital Expansion

2025

Working Capital Expansion

2025

Capex Efficiency Stress

Key Financials (INR Cr)

PeriodRevenueNet ProfitOCFDebt
FY20261,437-7491,276
FY20251,462-18-22772